LAWRENCE, Mass. —
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite, has received FDA clearance.
Early state vascular devices maker Flow Forward emerged from the nest, so to speak, spinning out of the Novita life sciences incubator in Olathe, Kansas.
Founded in 2011, Flow Forward is taking with it the AFE System, a device intended to help more patients undergo hemodialysis via an arteriovenous fistula (AVF), the gold standard in vascular access sites.